Encompass Health Corporation $EHC Stock Holdings Lessened by Polar Capital Holdings Plc

Polar Capital Holdings Plc lessened its stake in shares of Encompass Health Corporation (NYSE:EHC) by 3.5% in the fourth quarter, Holdings Channel.com reports. The fund owned 469,514 shares of the company’s stock after selling 16,916 shares during the quarter. Polar Capital Holdings Plc’s holdings in Encompass Health were worth $49,834,000 at the end of the most recent reporting period.

A number of other hedge funds have also modified their holdings of EHC. Northwestern Mutual Wealth Management Co. increased its stake in Encompass Health by 3,059,159.7% in the 4th quarter. Northwestern Mutual Wealth Management Co. now owns 3,793,482 shares of the company’s stock worth $402,640,000 after purchasing an additional 3,793,358 shares in the last quarter. AlphaCore Capital LLC acquired a new position in shares of Encompass Health in the fourth quarter worth about $4,881,000. JPMorgan Chase & Co. boosted its holdings in shares of Encompass Health by 5.3% in the third quarter. JPMorgan Chase & Co. now owns 1,410,335 shares of the company’s stock worth $179,141,000 after buying an additional 70,387 shares during the period. Tudor Investment Corp ET AL increased its position in shares of Encompass Health by 155.3% in the third quarter. Tudor Investment Corp ET AL now owns 210,712 shares of the company’s stock worth $26,765,000 after acquiring an additional 128,191 shares in the last quarter. Finally, SG Americas Securities LLC raised its holdings in shares of Encompass Health by 1,070.9% during the fourth quarter. SG Americas Securities LLC now owns 88,054 shares of the company’s stock valued at $9,346,000 after acquiring an additional 80,534 shares during the period. 97.25% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

A number of equities analysts recently commented on the stock. Barclays decreased their price objective on shares of Encompass Health from $153.00 to $140.00 and set an “overweight” rating for the company in a research note on Tuesday, May 5th. Weiss Ratings restated a “buy (b-)” rating on shares of Encompass Health in a report on Monday, June 8th. Wall Street Zen raised Encompass Health from a “hold” rating to a “buy” rating in a research report on Saturday, May 2nd. TD Cowen assumed coverage on Encompass Health in a report on Thursday, May 28th. They set a “buy” rating and a $125.00 price target on the stock. Finally, Leerink Partners set a $152.00 price objective on Encompass Health in a research note on Friday, May 22nd. One investment analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating and one has given a Hold rating to the company. According to data from MarketBeat.com, the company currently has an average rating of “Buy” and a consensus price target of $143.86.

Encompass Health Stock Performance

Shares of EHC opened at $99.92 on Wednesday. The company has a market capitalization of $9.91 billion, a PE ratio of 16.68, a PEG ratio of 2.17 and a beta of 0.72. The company has a debt-to-equity ratio of 0.76, a quick ratio of 1.17 and a current ratio of 1.17. The company’s 50 day moving average price is $104.40 and its 200 day moving average price is $104.36. Encompass Health Corporation has a 52 week low of $92.77 and a 52 week high of $127.99.

Encompass Health (NYSE:EHC) last issued its earnings results on Thursday, April 30th. The company reported $1.60 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.51 by $0.09. Encompass Health had a net margin of 10.04% and a return on equity of 18.28%. The company had revenue of $1.59 billion during the quarter, compared to analyst estimates of $1.57 billion. During the same quarter last year, the business posted $1.37 EPS. The company’s revenue for the quarter was up 9.0% on a year-over-year basis. Encompass Health has set its FY 2026 guidance at 5.890-6.110 EPS. Research analysts expect that Encompass Health Corporation will post 5.97 EPS for the current fiscal year.

Encompass Health Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Wednesday, July 15th. Shareholders of record on Wednesday, July 1st will be paid a $0.19 dividend. The ex-dividend date is Wednesday, July 1st. This represents a $0.76 dividend on an annualized basis and a yield of 0.8%. Encompass Health’s payout ratio is 12.69%.

Insiders Place Their Bets

In other news, EVP Patrick William Tuer sold 682 shares of the firm’s stock in a transaction dated Monday, May 11th. The stock was sold at an average price of $104.56, for a total transaction of $71,309.92. Following the completion of the sale, the executive vice president directly owned 24,755 shares of the company’s stock, valued at $2,588,382.80. This trade represents a 2.68% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. 1.80% of the stock is currently owned by insiders.

Encompass Health Profile

Encompass Health Corporation is a leading provider of post?acute healthcare services in the United States, operating a comprehensive network of inpatient rehabilitation hospitals and home health and hospice agencies. Its inpatient rehabilitation hospitals offer intensive therapy programs for patients recovering from conditions such as stroke, brain injury, spinal cord injury, cardiac and pulmonary disorders, and orthopedic procedures. Through its home health segment, Encompass Health delivers skilled nursing, physical therapy, occupational therapy and speech therapy to patients in the comfort of their homes, while its hospice services provide end?of?life care focused on symptom management and emotional support for patients and families.

Founded in 1984 as HealthSouth Corporation and rebranded as Encompass Health in 2018, the company has grown organically and through acquisitions to serve patients across more than 30 states.